Position
Chief Executive Officer
Company
QBiotics Group Limited
Description
Stephen Doyle has been appointed as the Chief Executive Officer of QBiotics, effective from 2 September 2024. Stephen brings over 24 years of global pharmaceutical executive experience, with expertise in the discovery and development of new drugs, bringing them to market, and diversifying treatment options for patients.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months